TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/24 14:07 | 4/19/24 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Juda Scott | FL | D | P.ad | 246 | 8.32 | 0 | 30 | 80 | 67 | D | |||||||||||||||
11/13/23 11:31 | 11/10/23 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Juda Scott | FL | D | P | 49 | 6.95 | 0 | 7 | 23 | 37 | I | |||||||||||||||
11/17/21 18:10 | 11/17/21 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Juda Scott | FL | D | P | 34 | 13.55 | 0 | 3 | 9 | 30 | I | |||||||||||||||
8/22/19 16:30 | 8/20/19 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Juda Scott | CA | D | P.m | 30 | 6.00 | 0 | 5 | 22 | 28 | D | |||||||||||||||
6/4/19 16:39 | 6/3/19 | INMB | Inmune Bio, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Juda Scott | CA | D | P | 60 | 6.00 | 0 | 10 | 80 | 23 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |